Incidence, management and prognosis of new-onset sarcoidosis post COVID-19 infection
CONCLUSIONS: Our result suggests there is a potential link between COVID-19 and new-onset sarcoidosis. The potential mechanism for this is through cytokine mediated immune modulation in COVID-19 infection. Obtaining a tissue sample remains key in confirming the diagnosis of sarcoidosis and this may be delayed during active COVID-19 infection.PMID:38567560 | PMC:PMC11008326 | DOI:10.36141/svdld.v41i1.15027
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - Category: Respiratory Medicine Authors: Oliver Vij Mrinalini Dey Kirsty Morrison Koushan Kouranloo Source Type: research
More News: Cardiology | COVID-19 | Heart | Heart Transplant | Intensive Care | Lung Transplant | Respiratory Medicine | Sarcoidosis | SARS | Transplant Surgery | Transplants | Vasculitis